Long-Term Efficacy of Zoledronic Acid for the Prevention of Skeletal Complications in Patients With Metastatic Hormone-Refractory Prostate Cancer.
Saad, Fred 1; Gleason, Donald M. 2; Murray, Robin 3; Tchekmedyian, Simon 4; Venner, Peter 5; Lacombe, Louis 6; Chin, Joseph L. 7; Vinholes, Jeferson J. 8; Goas, J. Allen 9; Zheng, Ming 9; For the Zoledronic Acid Prostate Cancer Study Group
Journal of the National Cancer Institute.
96(11):879-882, June 2, 2004.
(Format: HTML, PDF)